Washington, DC - The bedding company, Mattress Firm, is offering students not-so-strenuous internships this summer. 

San Diego, California - Assistant Secretary of State for Consular Affairs Carl Risch is traveling May 5-7 to San Diego, California and Tijuana, Mexico. In San Diego, he will visit the U.S. passport agency and then meet with foreign government counterparts from Australia, Canada, Ireland, New Zealand, and the United Kingdom at the annual Five Nations meeting on passport operations.

Washington, DC - On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. Vyndaqel and Vyndamax have the same active moiety, tafamidis, but they are not substitutable on a milligram to milligram basis and their recommended doses differ.

Charlotte, North Carolina - Two former executives were charged in an indictment unsealed Thursday for their alleged participation in an insurance investment scheme that resulted in hundreds of millions of dollars in victim losses.

Dallas, Texas - American Heart Association CEO Nancy Brown issued the following statement about the launch of the National Academy of Medicine’s Action Collaborative for Countering the U.S. Opioid Epidemic.

Bridgeport, Connecticut - Michael S. Flynn, executive and co-owner of an insulation contractor, pleaded guilty Wednesday in Bridgeport, for his role in multiple schemes to rig bids in violation of the antitrust laws and to engage in criminal fraud on insulation contracts, marking the second conviction in this ongoing investigation, the Department of Justice announced.